Search Results

Filter
  • 1-10 of  67,839 results for ""Diabetic Nephropathies""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Neferine inhibits the progression of diabetic nephropathy by modulating the miR-17-5p/nuclear factor E2-related factor 2 axis.

  • Authors : Hongmei H; Department of Endocrinology, Chengdu Shuangliu District First People's Hospital (West China Airport of Sichuan University), Chengdu 610200, China.; Maojun Y

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/genetics ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism

  • Source: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan [J Tradit Chin Med] 2024 Feb; Vol. 44 (1), pp. 44-53.Publisher: Academy Of Traditional Chinese Medicine Country of Publication: China NLM ID: 8211546 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.

  • Authors : Wang Y; Department of Nephrology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China. Electronic address: .; Peng L

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/prevention & control ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism

  • Source: Journal of ethnopharmacology [J Ethnopharmacol] 2024 Apr 24; Vol. 324, pp. 117721. Date of Electronic Publication: 2024 Jan 08.Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Irbesartan ameliorates diabetic nephropathy by activating the Nrf2/Keap1 pathway and suppressing NLRP3 inflammasomes in vivo and in vitro.

  • Authors : Li Y; State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Department of Endocrinology and Department of Interventional Therapy of First Hospital of Jilin University, Jilin University, Changchun 130000, China; Innovation Pharmaceutical Research Institute of Shijiazhuang No. 4 Pharmaceutical Co., Ltd.;Hebei Guangxiang Pharmaceutical Co., Ltd., Shijiazhuang, 050000, China

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism ; Diabetes Mellitus*

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Apr 20; Vol. 131, pp. 111844. Date of Electronic Publication: 2024 Mar 18.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

SGLT2 knockdown restores the Th17/Treg balance and suppresses diabetic nephropathy in db/db mice by regulating SGK1 via Na .

  • Authors : Wang D; Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Zhang Q

Subjects: Diabetes Mellitus*/Diabetes Mellitus*/Diabetes Mellitus*/metabolism ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/genetics ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism

  • Source: Molecular and cellular endocrinology [Mol Cell Endocrinol] 2024 Apr 15; Vol. 584, pp. 112156. Date of Electronic Publication: 2024 Jan 24.Publisher: North Holland Publishing Country of Publication: Ireland NLM ID: 7500844 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.

  • Authors : Mazzieri A; Diabetes Clinic, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.; Porcellati F

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/etiology ; Diabetes Mellitus*

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 03; Vol. 25 (7). Date of Electronic Publication: 2024 Apr 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Long noncoding RNA Glis2 regulates podocyte mitochondrial dysfunction and apoptosis in diabetic nephropathy via sponging miR-328-5p.

  • Authors : Wang T; Department of Endocrinology, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.; Chen Y

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/genetics ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/pathology ; RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics

  • Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2024 Apr; Vol. 28 (7), pp. e18204.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print Cited Medium: Internet ISSN: 1582-4934

Record details

×
Academic Journal

Risk Factors and Frequency of Foot Ulceration in Patients Receiving Chronic Hemodialysis Treatment.

  • Authors : Özdemir VA; Vacide Aşik Özdemir, PhD, is Assistant Professor, Department of Internal Medicine Nursing, Faculty of Health Sciences, Recep Tayyip Erdogan University, Rize, Turkey. Nesrin Nural, PhD, is Professor, Department of Internal Medicine Nursing, Faculty of Health Sciences, Karadeniz Technical University, Trabzon, Turkey.; Nural N

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/epidemiology ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/therapy ; Kidney Failure, Chronic*/Kidney Failure, Chronic*/Kidney Failure, Chronic*/therapy

  • Source: Advances in skin & wound care [Adv Skin Wound Care] 2024 Apr 01; Vol. 37 (4), pp. 203-210.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100911021 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Icariin alleviates diabetic renal interstitial fibrosis aggravation by inhibiting miR-320a-3p targeting BMP6.

  • Authors : Wang K; School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China.; Hou M

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/genetics ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism

  • Source: Journal of pharmacological sciences [J Pharmacol Sci] 2024 Apr; Vol. 154 (4), pp. 316-325. Date of Electronic Publication: 2024 Feb 27.Publisher: Japanese Pharmacological Society Country of Publication: Japan NLM ID: 101167001 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Microbial imidazole propionate affects glomerular filtration rate in patients with diabetic nephropathy through association with HSP90α.

  • Authors : Lv D; Department of Nephrology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China; Department of Neuroscience Research Center, School of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/genetics ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism ; Diabetes Mellitus*

  • Source: Biochimica et biophysica acta. Molecular cell research [Biochim Biophys Acta Mol Cell Res] 2024 Apr; Vol. 1871 (4), pp. 119703. Date of Electronic Publication: 2024 Mar 05.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101731731 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The therapeutic effect of mesenchymal stem cells in diabetic kidney disease.

  • Authors : Habiba UE; Pak-American Hospital Pvt. Ltd, Jahangir Multiplex, Peshawar Road, Sector H-13, Islamabad, 44000, Pakistan. .; R3 Medical Research LLC, 10045 East Dynamite Boulevard Suite 260, Scottsdale, AZ, 85262, USA. .

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/therapy ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism ; Mesenchymal Stem Cell Transplantation*/Mesenchymal Stem Cell Transplantation*/Mesenchymal Stem Cell Transplantation*/methods

  • Source: Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2024 Apr; Vol. 102 (4), pp. 537-570. Date of Electronic Publication: 2024 Feb 29.Publisher: Springer International Country of Publication: Germany NLM ID: 9504370 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  67,839 results for ""Diabetic Nephropathies""